PR TIMES (3922) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Oct, 2026Executive summary
Q2 net sales rose 20.5% YoY to ¥2,369 million and operating profit rose 112.8% to ¥1,008 million, both quarterly records; operating margin reached 42.6%.
H1 FY2026 revenue increased 20.1% YoY to ¥4,674.389 million; operating profit rose 97.4% to ¥1,892.205 million and parent-attributable profit rose 100.4% to ¥1,272.321 million.
H1 sales, operating profit and profit exceeded initial forecasts by 5.6%, 28.5% and 28.3%, respectively.
Growth was supported by press release volumes, Jooto and Tayori progress, and stronger-than-expected orders at glucose inc. and NAVICUS Co., Ltd.
Financial highlights
H1 EBITDA was ¥2,043.527 million, up 92.0% YoY; gross profit rose to ¥3,935.736 million from ¥3,289.020 million.
Q2 EBITDA rose 106.6% YoY to ¥1,093 million; profit increased 122.8% to ¥699 million.
Operating cash flow was ¥1,650.089 million, compared with ¥479.908 million in H1 FY2025; cash and cash equivalents reached ¥7,016.616 million at August 31, 2025.
Outlook and guidance
FY2026 forecast: revenue ¥9,522 million (+19.0% YoY), EBITDA ¥3,973 million (+82.7%), operating profit ¥3,600 million (+91.8%), ordinary profit ¥3,581 million (+91.2%) and parent-attributable profit ¥2,410 million (+115.4%).
FY2026 EPS forecast is ¥178.65; year-end dividend guidance was raised to ¥13.60 per share, up 32.0% YoY, based on DOE of 2% or more.
Revised guidance progress was 49.1% for sales and 52.6% for operating profit, ahead of prior-year rates; guidance was characterized as conservative as upfront investment increases.
The FY2025 operating profit target of ¥3.5 billion under Milestone 2025 was expected to be surpassed; more ambitious FY2030 growth goals were set.
Latest events from PR TIMES
- Record quarterly revenue, lower FY sales guidance and higher dividend guidance.3922
Q2 2027 - FY2030 targets pair ¥7.0bn operating profit with expansion into AI, SaaS and North America.3922
Company presentation - Record Q1 revenue and 41% profit growth; full-year guidance unchanged.3922
Q1 2025 - Record Q2 sales, higher investment costs and a ¥3.5bn FY2025 milestone target.3922
Q2 2025 - Nine-month sales rose 18.7%; FY2025 operating-profit guidance increased to ¥3.0 billion+.3922
Q3 2025 - Record FY2024 sales; FY2025 guidance targets 67.7% operating-profit growth.3922
Q4 2025 - Record Q1 growth, unchanged FY2026 guidance and ongoing security remediation.3922
Q1 2026 - Record Q3 results and strong nine-month growth underpin guidance and planned investment.3922
Q3 2026 - Record FY2025 results fund an investment phase toward ¥7.0bn operating profit by 2030.3922
Q4 2026